IL10 and neoplasm: Conversely, Treg-derived IL-10 and IL-35 cooperatively upregulate the expression of multiple inhibitory receptors and drive BLIMP1-dependent exhaustion of tumor infiltration CD8+ T cells, further impeding antitumor immunity (110).